Dementia: Klotho Injection Improves Cognition in Monkey 

Researchers have found that memory in aged monkey improved following a single administration of low-dose Klotho protein. It is the first time that restoring levels of klotho has been shown to improve cognition in a non-human primate. This paves the way for clinical trials in future to test if klotho treatment may prove therapeutic in aging humans with dementia due to Alzheimer disease (AD).  

Klotho is a naturally occurring protein. It is mainly produced in the kidney and exists in three forms. Membrane Klotho is involved in aging and the development of chronic diseases. The secreted Klotho acts as humoral factor and in organ protection while intracellular form of Klotho protein supresses cellular senescence. It is called Longevity factor because of its anti-aging biological functions.  

The circulating levels of Klotho protein deceases with the age. A study on animal in 2015 had demonstrated that mice with reduced Klotho level had accelerated aging while increased levels of Klotho enhanced lifespan1. Similar results were found in another study reported in the same year on human amyloid precursor protein (hAPP) transgenic mice – increasing Klotho protein expression reduced premature mortality and neural network dysfunctions2. These animal experiments suggested that Klotho protein level plays a key role in aging which is very important risk factor for the most common neurodegenerative disorder called Alzheimer disease (AD).  

Association of Klotho with Alzheimer disease (AD) came to the fore courtesy a cross-sectional observational study reported last year. The study involved 243 patients with Alzheimer disease (AD) and cognitively healthy controls. It was found that Klotho levels in Cerebro-spinal fluid (CSF) were significantly higher among healthy controls. The individuals with dementia due to Alzheimer disease had lower Klotho CSF levels. Further, Klotho levels differed in clinical stages of Alzheimer disease3.  

Could restoring Klotho levels in individuals with dementia due to Alzheimer disease be an approach to treat and prevent such disorders? This may be possible only after clinical trials are conducted and safety and efficacy results are found to be satisfactory. But a milestone towards this has been reached for a non-human primate.  

In a study4 reported on 03 July 2023, the researchers found that memory in aged monkey was enhanced following a single administration of low-dose Klotho protein. It is the first time that restoring levels of klotho has been shown to improve cognition in a non-human primate. This paves the way for clinical trials to test if klotho treatment may prove therapeutic in aging humans. 

*** 

References: 

  1. Kim J. et al 2015. Biological Role of Anti-aging Protein Klotho. Journal of Lifestyle Medicine 2015; 5:1-6. Published online March 31, 2015; DOI: https://doi.org/10.15280/jlm.2015.5.1.1 
  1. Dubal D.B. et al. 2015. Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in hAPP Transgenic Mice. Journal of Neuroscience 11 February 2015, 35 (6) 2358-2371; DOI: https://doi.org/10.1523/JNEUROSCI.5791-12.2015 
  1. Grøntvedt G.R. et al 2022. Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden. JAMA Netw  Open. 2022;5(11):e2243232. DOI: https://doi.org/10.1001/jamanetworkopen.2022.43232 
  1. Castner, S.A., Gupta, S., Wang, D. et al. Longevity factor klotho enhances cognition in aged nonhuman primates. Nat Aging (2023). https://doi.org/10.1038/s43587-023-00441-x  

*** 

Latest

UK’s First Birth Following Living-donor Uterine Transplantation

The woman who had undergone the first living-donor uterus...

Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  

Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has...

JWST’s Deep Field Observations Contravene Cosmological Principle

James Webb Space Telescope’s deep field observations under JWST...

Long-chain Hydrocarbons Detected on Mars  

An analysis of existing rock sample inside Sample Analysis at...

Newsletter

Don't miss

UK’s First Birth Following Living-donor Uterine Transplantation

The woman who had undergone the first living-donor uterus...

Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  

Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has...

Titanium Device as a Permanent Replacement for a Human Heart  

Use of “BiVACOR Total Artificial Heart”, a titanium metal...

Hidden consciousness, Sleep spindles and Recovery in Comatose Patients 

Coma is a deep unconsciousness state associated with brain...

Adrenaline Nasal Spray for Treatment of Anaphylaxis in Children

The indication for adrenaline nasal spray Neffy has been expanded (by...
Umesh Prasad
Umesh Prasad
Editor, Scientific European (SCIEU)

Iboxamycin (IBX): a Synthetic Broad-Spectrum Antibiotic to address Anti-Microbial Resistance (AMR)

Development of multi-drug resistance (MDR) bacteria in the past five decades have led to increasing research in search of a drug candidate to address this AMR...

FDA approves Tecelra (a T cell receptor gene therapy) for Synovial Sarcoma 

Tecelra (afamitresgene autoleucel), a gene therapy for the treatment of adults with metastatic synovial sarcoma has been approved by the FDA. The approval was...

Advances in Regeneration of Damaged Heart

Recent twin studies have shown novel ways of regenerating a damaged heart Heart failure affects at least 26 million people worldwide and is responsible for...